Literature DB >> 28777258

Knockdown of long noncoding antisense RNA brain-derived neurotrophic factor attenuates hypoxia/reoxygenation-induced nerve cell apoptosis through the BDNF-TrkB-PI3K/Akt signaling pathway.

Jian-Bin Zhong1, Xie Li, Si-Ming Zhong, Jiu-Di Liu, Chi-Bang Chen, Xiao-Yan Wu.   

Abstract

Brain-derived neurotrophic factor (BDNF) plays an important role in neuronal cell apoptosis. The antisense RNA of brain-derived neurotrophic factor (BDNF-AS) is a natural antisense transcript that is transcribed opposite the gene that encodes BDNF. The aim of this study was to determine whether knockdown of BDNF-AS can suppress hypoxia/reoxygenation (H/R)-induced neuronal cell apoptosis and whether this is mediated by the BDNF-TrkB-PI3K/Akt pathway. We detected the expression of BDNF and BDNF-AS in brain tissue from 20 patients with cerebral infarction and five patients with other diseases (but no cerebral ischemia). We found that BDNF expression was significantly downregulated in patients with cerebral infarction, whereas the expression of BDNF-AS was significantly upregulated. In both human cortical neurons (HCN2) and human astrocytes, H/R significantly induced the expression of BDNF-AS, but significantly decreased BDNF expression. H/R also significantly induced apoptosis and reduced the mitochondrial membrane potential in these cells. Following downregulation of BDNF-AS by siRNA in human cortical neurons and human astrocyte cells, BDNF expression was significantly upregulated and the H/R-induced upregulation of BDNF-AS was significantly attenuated. BDNF-AS siRNA inhibited H/R-induced cell apoptosis and ameliorated the H/R-induced suppression of mitochondrial membrane potential. H/R inhibited the expression of BDNF, p-AKT/AKT, and TrKB, and this inhibition was recovered by BDNF-AS siRNA. In summary, this study indicates that BDNF-AS siRNA induces activation of the BDNF-TrkB-PI3K/Akt pathway following H/R-induced neurotoxicity. These findings will be useful toward the application of BDNF-AS siRNA for the treatment of neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28777258     DOI: 10.1097/WNR.0000000000000860

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

Review 1.  LncRNAs as the Regulators of Brain Function and Therapeutic Targets for Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Chen; Yutong Che; Hongli Li; Zheyu Zhang; Weijun Peng; Jingjing Yang
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 2.  Long Non-coding RNA in CNS Injuries: A New Target for Therapeutic Intervention.

Authors:  Li Zhang; Handong Wang
Journal:  Mol Ther Nucleic Acids       Date:  2019-07-29       Impact factor: 8.886

3.  Overexpression of Brain- and Glial Cell Line-Derived Neurotrophic Factors Is Neuroprotective in an Animal Model of Acute Hypobaric Hypoxia.

Authors:  Maria S Gavrish; Mark D Urazov; Tatiana A Mishchenko; Victoria D Turubanova; Ekaterina A Epifanova; Victoria G Krut'; Alexey A Babaev; Maria V Vedunova; Elena V Mitroshina
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

4.  AAV-Syn-BDNF-EGFP Virus Construct Exerts Neuroprotective Action on the Hippocampal Neural Network during Hypoxia In Vitro.

Authors:  Еlena V Mitroshina; Tatiana A Mishchenko; Alexandra V Usenko; Ekaterina A Epifanova; Roman S Yarkov; Maria S Gavrish; Alexey A Babaev; Maria V Vedunova
Journal:  Int J Mol Sci       Date:  2018-08-05       Impact factor: 5.923

5.  Brain-Derived Neurotrophic Factor Alleviates Ropivacaine-Induced Neuronal Damage by Enhancing the Akt Signaling Pathway.

Authors:  Yongyi Zhai; Yong Ma; Jingying Liu; Yulin Zhu; Kun Xie; Lingzhi Yu; Hao Zhang
Journal:  Med Sci Monit       Date:  2019-12-30

6.  Cholic Acid Protects In Vitro Neurovascular Units against Oxygen and Glucose Deprivation-Induced Injury through the BDNF-TrkB Signaling Pathway.

Authors:  Changxiang Li; Xueqian Wang; Juntang Yan; Fafeng Cheng; Xiaona Ma; Congai Chen; Wei Wang; Qingguo Wang
Journal:  Oxid Med Cell Longev       Date:  2020-10-10       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.